SPARC and obesity due to melanocortin 4 receptor deficiency: Therefore, to test whether our findings of reduction of SPARC in adipose tissue in humans undergoing CR are causally linked to enhanced metabolic health, we developed new genetic mouse models to determine the role of SPARC in the context of obesity.